Respiratory Infections News

Support staff and Black and Latinx workers with and without patient care faced the highest risk for SARS-CoV-2 infection in a study of nearly 4,000 hospital employees and clinicians in New Jersey.

President-elect Joseph R. Biden Jr. and Vice President-elect Kamala Harris announced a 13-member COVID-19 advisory board and a seven-point plan to fight the virus.

Phase 3 clinical trial results indicate that Russia’s Sputnik V vaccine was 92% effective against COVID-19, according to a press release from the Russian Direct Investment Fund, or RDIF.

Influenza infection during pregnancy is associated with late-term pregnancy loss and reduced birth weight, according to study findings published in The Lancet Infectious Diseases.

A novel artificial intelligence-generated score can predict the prognosis of patients who present with COVID-19 in the outpatient setting, according to results from a single-center study published in The Journal of Infectious Diseases.

The FDA authorized the emergency use of Eli Lilly’s investigational monoclonal antibody therapy to treat mild-to-moderate COVID-19 in adults and children.

After a student at an overnight retreat in Wisconsin began exhibiting symptoms of SARS-CoV-2 infection this summer, the virus spread rapidly, infecting more than three-quarters of attendees, researchers said.

Weekly aggregate medical spending by most commercial insurance customers and Medicare Advantage recipients in the United States dropped by nearly half as the COVID-19 pandemic progressed, data show.

A vaccine candidate developed by Pfizer and BioNTech was more than 90% effective in preventing COVID-19 and showed no serious safety concerns, according to an interim analysis of phase 3 clinical trial results released by the companies.

COVID-19 may not be characterized by the presence of a cytokine storm, an abnormal strong proinflammatory response, according to results published in JAMA.